A5065833725- Endometrial and Cervical Cancer Treatments
- Cervical Cancer and HPV Research
- Ovarian cancer diagnosis and treatment
- Colorectal and Anal Carcinomas
- Gestational Trophoblastic Disease Studies
- Cancer-related molecular mechanisms research
- Multiple and Secondary Primary Cancers
- Urticaria and Related Conditions
- Venous Thromboembolism Diagnosis and Management
- Cancer Diagnosis and Treatment
- Prenatal Screening and Diagnostics
- Endometriosis Research and Treatment
- MicroRNA in disease regulation
- Sexual function and dysfunction studies
- Extracellular vesicles in disease
- Fungal Infections and Studies
- Circular RNAs in diseases
- Lymphatic Disorders and Treatments
- Autophagy in Disease and Therapy
- Urinary Tract Infections Management
- Cancer survivorship and care
- PARP inhibition in cancer therapy
- Corneal Surgery and Treatments
- Nonmelanoma Skin Cancer Studies
- Ovarian function and disorders
Siriraj Hospital
2008-2025
Mahidol University
2009-2025
University of Indonesia
2021
All India Institute of Medical Sciences
2021
Ramathibodi Hospital
2021
The situation of patients developing multiple primary cancers is becoming more frequent and graver. This study investigated the risks second that are related to first cancers, interval times synchronous metachronous cancers.Retrospective data were retrieved from 109,054 aged ≥18 who diagnosed with a solid cancer registered at Siriraj Cancer Center between 1991 2015. A two-month period first- second- was used differentiate cancers. combinations subsequent relative (RRs) having versus single...
Please cite this paper as: Wilailak S, Vipupinyo C, Suraseranivong V, Chotivanich K, Kietpeerakool Tanapat Y, Therasakvichya Hamontri Linasmita Bunyapipat Chindavijak Ittiwisavakul Khemapech N, Suekwattana P, Thanapprapasr D, Lumbiganon P. Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case–control study. BJOG 2012;119:672–677. Objective To evaluate the effect of depot (DMPA) in protecting against cancer (EOC) to factors associated with risk EOC. Design A...
The tumor microenvironment composed of a mixture stromal cells and their secretions has marked impact on cancer progression. In particular, soluble factors metabolites contribute to malignancy through the dysregulation autophagy in cells. present study investigated effects ovarian cancer‑associated fibroblasts (OVCAFs) with secretory substances migration conditioned‑medium (CM) OVCAFs isolated from fresh human tissues was analyzed for levels 27 common cytokines/chemokines using cytokine...
To evaluate the rate of pathologic high-risk factors, intermediate-risk and treatment outcomes in early-stage cervical cancer patients undergoing radical hysterectomy pelvic lymphadenectomy (RHPL).Medical records stage IA-IIA1 who underwent RHPL during 2006 to 2012 time period patient follow-up data until December 2013 were reviewed.Of 331 patients, 52 women (15.7%) had factors 59 (17.8%) without factors. All studied an initial complete response. At median 40.9 months (range 1-103.3 months)...
To review ovarian cancer cases in children and adolescents Siriraj Hospital assess the prognosis, recurrence of disease, reproductive outcomes after treatment.A retrospective descriptive study was conducted patients 21 years younger who had been treated at between January 1990 December 2009. Medical records were reviewed relevant data recorded.A total 48 met criteria; their mean age 16.4 years. Abdominal distension major symptom. 91.6% germ cell tumors remaining sex cord-stromal epithelial...
To assess the efficacy and tolerability of combination therapy with capecitabine cisplatin in patients recurrent carcinoma uterine cervix.Sixteen were treated oral (1,000 mg/m2 twice daily, days 1-14) intravenous (50 mg/m(2) on day 1 every 3 weeks) for a maximum six cycles.Their median age was 50 years (31-74 years). Ten (63%) had disease outside radiation field. The overall response rate 50% (95% confidence interval 26-75%); 4 complete (25%). 33% within previous irradiated field 60% tumor...
The Asian Society of Gynecologic Oncology International Workshop 2018 on gynecologic oncology was held in the Ajou University Hospital, Suwon, Korea 24th to 25th August 2018. workshop an opportunity for doctors discuss latest findings cancer, including cervical, ovarian, and endometrial cancers, as well future fertility-sparing treatments, minimally invasive/radical/debulking surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy. Clinical guidelines position statement...
To study the incidence of non-endometrioid carcinoma endometrium and compare clinical characteristics treatment outcomes with endometrioid patients.This included 236 patients endometrial at Siriraj Hospital whom were diagnosed treated from 2003 through 2006. The characteristics, pathological features, collected medical records. 5-year survival was calculated according to 2009 FIGO staging.Non-endometrioid accounted for 10.2% all carcinomas (24/236 patients). 5 -year rate significantly lower...
Objective: To evaluate the recurrence rates and patterns of failure in patients with stage I endometrial carcinoma after surgical staging without adjuvant therapy.Methods: Medical records 229 carcinoma, treated surgery alone between 2002 2010 at Siriraj Hospital were retrospectively reviewed.The primary objective this study was rates.The secondary objectives failure, disease-free survival, overall prognostic factors related to outcomes.Results: During median follow-up time 53.3 months, 11...
To investigate the distribution of human papillomavirus (HPV) genotypes in low-grade squamous intraepithelial lesion (LSIL) cytology and immediate risk cervical neoplasia grade 2 or higher (CIN2+) lesions. This prospective cross-sectional study enrolled women aged ≥21 years that were diagnosed with LSIL at Siriraj Hospital (Bangkok, Thailand) during 2017-2019. Anyplex II HPV testing was performed to detect 14 high-risk cases prior colposcopy-directed biopsy. In total, 318 patients included...
To determine response rate and survival outcomes of chemotherapeutic treatment in stage IVB, persistent, or recurrent cervical carcinoma patients.Medical records IVB persistent patients who received chemotherapy from January 2006 to December 2013 were retrospectively reviewed. Patients with neuroendocrine only 1 cycle excluded. The demographic data, tumor characteristics, agents, reported. Factors associated overall the first-round analyzed using χ test. Kaplan-Meier method Cox proportional...
Immediate hypersensitivity reactions (IHRs) are commonly found in patients receiving paclitaxel. Effects of paclitaxel vary because variable co-therapy or re-challenge with paclitaxel.Our objective was to investigate the incidence, patterns, and risk factors for paclitaxel-related IHRs management gynecologic malignancy patients.This retrospective study performed cancer paclitaxel-based regimens at Siriraj hospital from January 2012 December 2017.416 subjects were included received ranitidine...